Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2010/02/01
-
Indian UGC (journal)
-
Refrences94
-
Citations54
-
Ramachandran Venkitaraman
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1056/NEJMoa0900212 | New England Journal of Medicine |
| 2009 | |
| Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings | Radiology |
| 253 | 2009 |
| Triple negative breast cancer - current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment | Biomedical Papers |
| 30 | 2009 |
| Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers | Breast Cancer Research and Treatment |
| 74 | 2009 |
| Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity | Breast Cancer Research and Treatment |
| 138 | 2009 |
Refrences Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 64
is the most frequently represented among the references in this article. It primarily includes studies from Breast Cancer Research and Treatment and Cancer. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
FOXO1 promotes the expression of canonical WNT target genes in examined basal‐like breast and glioblastoma multiforme cancer cells | FEBS Open Bio |
| 2023 | |
C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration | Molecular Cancer Therapeutics |
| 2023 | |
| Multiomics of HER2-low triple-negative breast cancer identifies a receptor tyrosine kinase–relevant subgroup with therapeutic prospects | JCI Insight |
| 1 | 2023 |
| Solasodine suppress MCF7 breast cancer stem-like cells via targeting Hedgehog/Gli1 | Phytomedicine |
| 2 | 2022 |
Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis | Nature Communications |
| 16 | 2022 |
Citations Analysis
The category
Medicine: Medicine (General) 27
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Serum appearance of anti-p53 antibody in triple negative breast cancer and was published in 2010. The most recent citation comes from a 2023 study titled Multiomics of HER2-low triple-negative breast cancer identifies a receptor tyrosine kinase–relevant subgroup with therapeutic prospects. This article reached its peak citation in 2021, with 10 citations. It has been cited in 45 different journals, 33% of which are open access. Among related journals, the Breast Cancer Research cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.